PER 1.35% 7.5¢ percheron therapeutics limited

Marketing is the weakness for Aussie bio stocks which want to...

  1. 2,197 Posts.
    lightbulb Created with Sketch. 160
    Marketing is the weakness for Aussie bio stocks which want to have market share in US, my other holding TD1 has the same problem as ANP, great product, equal or greater compared to their US counterpart(s), but does not have the fund and resources to open market in US, have to team up with US company and sell themselves short…… but even so is great, the first step of a long journey years to come
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
0.001(1.35%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.7¢ 7.8¢ 7.4¢ $24.63K 325.4K

Buyers (Bids)

No. Vol. Price($)
2 142779 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8181 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.